TB Bacteria Stiffen Cell Membranes to Block Their Own Destruction

Tuberculosis kills more than one million people per year. The bacterium that causes it, Mycobacterium tuberculosis, has evolved over millennia alongside its human host, developing sophisticated ways to survive inside the very immune cells sent to destroy it. A new study has identified one of those mechanisms - and it is based not on protein chemistry but on physics.

When immune cells called macrophages engulf bacteria, they trap them inside a membrane-bound compartment called a phagosome. Normally, the phagosome then fuses with lysosomes - organelles packed with digestive enzymes - and the bacteria are broken down. Mycobacteria interrupt this sequence. Researchers had identified various proteins the bacteria deploy to block phagosome-lysosome fusion, but Ayush Panda and colleagues at the National Institute of Science Education and Research (NISER) in India have now identified a separate, lipid-driven mechanism. Their findings were presented at the 70th Biophysical Society Annual Meeting in San Francisco in February 2026 and posted on bioRxiv.

Fatty Packages That Remodel Host Cell Membranes

The bacteria release tiny membrane-enclosed particles called extracellular vesicles. These vesicles carry specialized lipids - fatty molecules with particular physical properties - that fuse with the membranes of nearby immune cells. Once incorporated, these bacterial lipids alter the physical properties of the phagosome membrane: they make it substantially more rigid.

Membrane rigidity directly affects fusion capacity. Biological membrane fusion - the merging of two lipid bilayers - requires the membrane to deform, bend, and mix. A membrane that has been stiffened by bacterial lipids resists this deformation. The phagosome and lysosome approach each other but cannot complete the fusion event. The bacteria remain encapsulated in their protective compartment, isolated from the digestive machinery that would otherwise kill them.

"If the membrane becomes more rigid, it becomes much harder for the phagosome to fuse with the lysosome," said Panda, formerly a graduate student in the laboratory of Mohammed Saleem at NISER. "It's an elegant biophysical mechanism: the bacteria remodel the membrane architecture to escape the very process that would have killed them."

A Lipid-Centered View of Immune Evasion

Previous research on mycobacterial immune evasion focused primarily on proteins - bacterial effector molecules that directly interfere with the cellular machinery governing phagosome maturation. This study takes a different approach, one centered on the physical properties of cell membranes rather than specific molecular interactions.

"The most surprising finding was when we introduced mycobacterial lipids into membranes that mimic the host phagosome, we saw remarkable physical changes - the membrane properties were completely altered," Panda said.

The team demonstrated these effects using model membrane systems - synthetic lipid bilayers engineered to mimic phagosome composition. Introducing mycobacterial lipids into these model membranes produced measurable increases in rigidity. The findings were corroborated in cell-based experiments showing reduced phagosome-lysosome fusion in the presence of mycobacterial vesicles.

Bystander Cells Are Also Affected

A particularly striking aspect of the findings is that the vesicles are not limited to infected cells. They diffuse through tissues and can alter the membranes of nearby immune cells that have not themselves encountered bacteria. This means mycobacteria can weaken the immune response in advance, impairing macrophages before those cells ever make contact with the pathogen.

The team also observed similar extracellular vesicle-mediated membrane effects in two other bacterial pathogens: Klebsiella pneumoniae and Staphylococcus aureus. This suggests the lipid-mediated membrane-stiffening strategy may represent an evolutionarily conserved immune evasion mechanism, not one unique to mycobacteria.

Potential Paths to New Treatments

Understanding the mechanism opens several therapeutic angles. Drugs that inhibit the production or secretion of bacterial extracellular vesicles could prevent the lipid payload from ever reaching host membranes. Alternatively, compounds that counteract the membrane-stiffening effects of bacterial lipids - perhaps by altering host membrane lipid composition - could restore the phagosome's ability to fuse with lysosomes and complete pathogen destruction.

"Now that we understand how the bacteria protect themselves, we can start looking for ways to stop them," Panda said. "If we can block the bacteria from stiffening those membranes, our immune cells might be able to do their job and stop the infection."

The findings are preliminary in important respects. The work relied on model membrane systems and cell culture experiments; demonstrating that the same lipid-mediated membrane changes occur in vivo, in animal models of tuberculosis infection, is a necessary next step. The identity of the specific bacterial lipids responsible and the host lipid targets they interact with also require further characterization before therapeutic design can begin in earnest. Still, the identification of a physical rather than purely biochemical evasion strategy adds a new dimension to the understanding of how one of the world's most persistent pathogens survives inside us.